Corporate Membership

Join Us

Elevate Your Brand and Succeed with ACT

ACT maintains a highly visible, well-regarded presence in the toxicology community through educational programs, professional networking opportunities, and our scientific journal.

Corporate support is essential to the continued success of the College and the achievement of its goals, and the ACT corporate membership program is a highly visible way for companies with a vested interest in the field of toxicology to show their support for the vital work of the College. In return, ACT corporate members benefit by elevating their brand and credibility as an ACT partner.

Why Join Forces with ACT?

ACT is a leader in toxicology education, offering well-regarded resources:

Signature Webinars
ToxChats Podcasts
Education Courses
eLearning Seminars
Annual Meeting—CE Courses, Symposia, Exhibition
International Journal of Toxicology

Who We Are and Who You Reach

ACT members are professional scientists, postdocs, and students representing:

Pharmaceutical and Biotech Industries
Contract Research Organizations
Regulatory Agencies
Academia
Consulting Firms

Corporate Membership Packages

Choose from two distinct packages to elevate your brand and maximize your reach.

Corporate Partner ($3,500 per Year):

Five job postings for six months each ($1,250 value)
Enhanced listing with hyperlink in the membership Newsletter
Enhanced listing with your logo in an issue of International Journal of Toxicology
Recognition in the Program and on signage at the ACT Annual Meeting
One blog post with your unique content in the ACTalks blog

One additional Exhibitor Priority Point for companies that also exhibit at the Annual Meeting, and Priority exhibit booth selection at the Annual Meeting
Logo on the ACT website home page
ACT Corporate Member logo for use on your company website
Enhanced listing on the ACT website with your logo, company description (30 words), and hyperlink to your company’s website

Corporate Contributor ($2,000 per Year):

Two job postings for six months each ($500 value)
Listing of company name in the membership Newsletter
Listing of company name in an issue of International Journal of Toxicology
Listing of company name with hyperlink on the ACT website
Recognition in the Program and on signage at the ACT Annual Meeting
Priority exhibit booth selection at the Annual Meeting in November

To take advantage of ACT Corporate Membership, please contact Art Shaw, 703.547.0875 ext. 1455.

2023 Corporate Members

ACT Corporate Members provide a sustained and important contribution to our success with their financial contributions, helping ACT pursue key strategic initiatives and deliver timely educational programs.

ACT Corporate Partners 2023

Charles River has a global network of scientific experts offering robust safety assessments of drugs, devices, and chemicals. Experience with all molecules types and regulations to mitigate risk for development.

Learn more

Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases.

Learn more

Lovelace Biomedical is a preclinical contract research organization helping pharmaceutical and biotechnology companies advance their complex drug development studies, with multidisciplinary expertise in toxicology, gene therapy, infectious disease, medical countermeasures.

Learn more

Noble Life Sciences is a preclinical CRO with decades of experience in drug, vaccine, and device development. GLP and non-GLP services, PK/PD, safety, toxicology, and cell-based assays with a strong focus on oncology and infectious diseases.

Learn more

Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. We consistently translate science into medicine, leading to nine FDA-approved treatments and numerous product candidates.

Learn more

Corporate Contributors

ITR Laboratories Canada Inc.

Learn more